Author: Godwin Gwetu
123jump.com
Last Update: 7:17 AM ET February 03 2009
The pharmaceuticals company signed an agreement with Wyeth for the combination of the two companies as quarterly revenues decreased 4% from the previous year quarter to the current quarter $12.3 billion. The fourth quarter net income fell from $2.7 billion in the equivalent period in 2007 to $266 million. With an expected $4 billion in synergies being forecast, the combined company is positioned to have an unrivalled geographic presence.
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites.
Market data: BATS Exchange. Inc.
350 Fund Managers Interviews - 10-year Annual earnings on 4,600 U.S. companies - 20-quarter Earnings on 3,800 U.S. companies - 3,200 U.S. IPO Prospectuses
- 2,100 Economic data releases from U.S., EU, UK, India, HK and Australia. 10-year Annual reports on 3,500 U.S. companies -
U.S. Earnings Calendar with 4,800 companies - 90,000 10-K reports - 26,000 Global markets news archive - 2,200 Earnings Conference Call Summaries
